A citation-based method for searching scientific literature

Kirit Singh, Kelly M Hotchkiss, Kisha K Patel, Daniel S Wilkinson, Aditya A Mohan, Sarah L Cook, John H Sampson. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
66

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy.
Houshi Xu, Qingwei Zhu, Lan Tang, Junkun Jiang, Huiwen Yuan, Anke Zhang, Meiqing Lou. Cancer Cell Int 2021
9
33

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme.
Sabrina Heynckes, Karam Daka, Pamela Franco, Annette Gaebelein, Jan Hendrik Frenking, Roberto Doria-Medina, Irina Mader, Daniel Delev, Oliver Schnell, Dieter Henrik Heiland. BMC Cancer 2019
21
33

Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy.
Noelle Frey, David Porter. Biol Blood Marrow Transplant 2019
132
33

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Jann N Sarkaria, Leland S Hu, Ian F Parney, Deanna H Pafundi, Debra H Brinkmann, Nadia N Laack, Caterina Giannini, Terence C Burns, Sani H Kizilbash, Janice K Laramy,[...]. Neuro Oncol 2018
265
33

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, Annechien Plat, G Bea A Wisman, Harry Hollema, Toos Daemen, David N Church, Marco de Bruyn, Hans W Nijman. Oncoimmunology 2017
91
33

Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.
Xuejia Tang, Chenghai Zuo, Pengchao Fang, Guojing Liu, Yongyi Qiu, Yi Huang, Rongrui Tang. Front Oncol 2021
15
33

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Jun Wei, Jason Barr, Ling-Yuan Kong, Yongtao Wang, Adam Wu, Amit K Sharma, Joy Gumin, Verlene Henry, Howard Colman, Waldemar Priebe,[...]. Mol Cancer Ther 2010
201
33

Excitation-neurogenesis coupling in adult neural stem/progenitor cells.
Karl Deisseroth, Sheela Singla, Hiroki Toda, Michelle Monje, Theo D Palmer, Robert C Malenka. Neuron 2004
503
33

Radiomic biomarkers of tumor immune biology and immunotherapy response.
Jarey H Wang, Kareem A Wahid, Lisanne V van Dijk, Keyvan Farahani, Reid F Thompson, Clifton David Fuller. Clin Transl Radiat Oncol 2021
12
33

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.
Surasak Phuphanich, Christopher J Wheeler, Jeremy D Rudnick, Mia Mazer, Hongqian Wang, Miriam A Nuño, Jaime E Richardson, Xuemo Fan, Jianfei Ji, Ray M Chu,[...]. Cancer Immunol Immunother 2013
256
33

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Charles S Cobbs, Jason A Heth, Michael Salacz, Sarah Taylor, Stacy D D'Andre,[...]. J Transl Med 2018
237
33

Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging.
Tian Xie, Xiao Chen, Jingqin Fang, Wei Xue, Junfeng Zhang, Haipeng Tong, Heng Liu, Yu Guo, Yizeng Yang, Weiguo Zhang. Cytotherapy 2021
8
33

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.
Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, Orsolya Rajky, Gerda Ricken, Adelheid Wöhrer, Karin Dieckmann, Martin Filipits, Anita Brandstetter, Michael Weller,[...]. Neuro Oncol 2015
371
33

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, Andrew M Silverman, Luis Aparicio, Tim Chu, Darius Bordbar, David Shan, Jorge Samanamud, Aayushi Mahajan,[...]. Nat Med 2019
371
33

The entry of nanoparticles into solid tumours.
Shrey Sindhwani, Abdullah Muhammad Syed, Jessica Ngai, Benjamin R Kingston, Laura Maiorino, Jeremy Rothschild, Presley MacMillan, Yuwei Zhang, Netra Unni Rajesh, Tran Hoang,[...]. Nat Mater 2020
537
33

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
Qian-Ting Wang, Ying Nie, Sheng-Nan Sun, Tao Lin, Ru-Jin Han, Jun Jiang, Zhe Li, Jun-Qi Li, Yun-Peng Xiao, Yu-Ying Fan,[...]. Cancer Immunol Immunother 2020
32
33

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley,[...]. Mol Ther 2013
247
33

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala,[...]. J Clin Oncol 2015
33



Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
33

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
Max S Topp, Nicola Gökbuget, Anthony S Stein, Gerhard Zugmaier, Susan O'Brien, Ralf C Bargou, Hervé Dombret, Adele K Fielding, Leonard Heffner, Richard A Larson,[...]. Lancet Oncol 2015
786
33


EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
H Miao, N W Gale, H Guo, J Qian, A Petty, J Kaspar, A J Murphy, D M Valenzuela, G Yancopoulos, D Hambardzumyan,[...]. Oncogene 2015
109
33

Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Leying Zhang, Darya Alizadeh, Michelle Van Handel, Marcin Kortylewski, Hua Yu, Behnam Badie. Glia 2009
129
33

Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End.
Angeliki Datsi, Rüdiger V Sorg. Front Immunol 2021
7
33

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.
Karsten Geletneky, Jacek Hajda, Assia L Angelova, Barbara Leuchs, David Capper, Andreas J Bartsch, Jan-Oliver Neumann, Tilman Schöning, Johannes Hüsing, Birgit Beelte,[...]. Mol Ther 2017
127
33

Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Britta Engelhardt, Richard M Ransohoff. Trends Immunol 2012
373
33

Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
Rovel J Colaco, Pierre Martin, Harriet M Kluger, James B Yu, Veronica L Chiang. J Neurosurg 2016
140
33


Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste.
Stuart J Smith, Betty M Tyler, Toby Gould, Gareth J Veal, Noah Gorelick, Jonathan Rowlinson, Riccardo Serra, Alison Ritchie, Phillip Berry, Annette Otto,[...]. Clin Cancer Res 2019
26
33

Glioblastoma cancer stem cell biology: Potential theranostic targets.
Farzaneh Sharifzad, Saeid Ghavami, Javad Verdi, Soura Mardpour, Mahsa Mollapour Sisakht, Zahra Azizi, Adeleh Taghikhani, Marek J Łos, Esmail Fakharian, Marzieh Ebrahimi,[...]. Drug Resist Updat 2019
73
33

Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.
Geoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, Melissa S Thebeau, Maria P Czupryn, Leticia Tetteh, Cabell Eysmans, Allison Richards, Michael J Schell, Kate J Fisher,[...]. Clin Cancer Res 2015
172
33

m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells.
Qi Cui, Hailing Shi, Peng Ye, Li Li, Qiuhao Qu, Guoqiang Sun, Guihua Sun, Zhike Lu, Yue Huang, Cai-Guang Yang,[...]. Cell Rep 2017
701
33

Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Adam Wu, Jun Wei, Ling-Yuan Kong, Yongtao Wang, Waldemar Priebe, Wei Qiao, Raymond Sawaya, Amy B Heimberger. Neuro Oncol 2010
423
33


A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
C Hirschmann-Jax, A E Foster, G G Wulf, J G Nuchtern, T W Jax, U Gobel, M A Goodell, M K Brenner. Proc Natl Acad Sci U S A 2004
987
33


Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.
Lijie Zhai, Erik Ladomersky, Kristen L Lauing, Meijing Wu, Matthew Genet, Galina Gritsina, Balázs Győrffy, Priscilla K Brastianos, David C Binder, Jeffrey A Sosman,[...]. Clin Cancer Res 2017
104
33

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
Aida Karachi, Changlin Yang, Farhad Dastmalchi, Elias J Sayour, Jianping Huang, Hassan Azari, Yu Long, Catherine Flores, Duane A Mitchell, Maryam Rahman. Neuro Oncol 2019
48
33

FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia.
Maura C O'Leary, Xiaobin Lu, Ying Huang, Xue Lin, Iftekhar Mahmood, Donna Przepiorka, Denise Gavin, Shiowjen Lee, Ke Liu, Bindu George,[...]. Clin Cancer Res 2019
110
33

Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.
Surabhi Ranjan, Martha Quezado, Nancy Garren, Lisa Boris, Christine Siegel, Osorio Lopes Abath Neto, Brett J Theeler, Deric M Park, Edjah Nduom, Kareem A Zaghloul,[...]. BMC Cancer 2018
30
33

Drug transport across the blood-brain barrier.
William M Pardridge. J Cereb Blood Flow Metab 2012
813
33

Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas.
Rae Myers, Mary Harvey, Timothy J Kaufmann, Suzanne M Greiner, James W Krempski, Corey Raffel, Steven E Shelton, Diane Soeffker, Paula Zollman, Mark J Federspiel,[...]. Hum Gene Ther 2008
67
33

The immune landscape of common CNS malignancies: implications for immunotherapy.
Martina Ott, Robert M Prins, Amy B Heimberger. Nat Rev Clin Oncol 2021
30
33


New developments in FcepsilonRI regulation, function and inhibition.
Stefan Kraft, Jean-Pierre Kinet. Nat Rev Immunol 2007
409
33

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
Richard A Morgan, Laura A Johnson, Jeremy L Davis, Zhili Zheng, Kevin D Woolard, Elizabeth A Reap, Steven A Feldman, Nachimuthu Chinnasamy, Chien-Tsun Kuan, Hua Song,[...]. Hum Gene Ther 2012
213
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.